At the core of this is a recovery for its life science unit, which dipped last year as its boom from components for Covid ...
As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback